Theravance Biopharma Inc
TBPH
Market Cap$446.75M
Close$
$10.75
17.6% upside
Current Fair Value
17.6% upsideUndervalued by 17.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $446.75 Million |
|---|---|
| Enterprise Value | $393.48 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.0 |
| Beta | 0.29 |
| Outstanding Shares | 48,559,955 |
| Avg 30 Day Volume | 420,401 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.09 |
|---|---|
| PEG | 45.29 |
| Price to Sales | 9.14 |
| Price to Book Ratio | 2.29 |
| Enterprise Value to Revenue | 6.85 |
| Enterprise Value to EBIT | -7.38 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
ESG Score
No data
About Theravance Biopharma Inc
CEO: Rick Winningham